Monkeypox Treatment Market by Treatment Type, Route of Administration, Distribution Channel & Region | Forecast 2023 to 2033

<p>The global <strong>monkeypox treatment market</strong> is expected to reach a valuation of<strong> US$ 93.84 million </strong>in 2023 and is projected to grow to <strong>US$ 249 million </strong>by 2033,<strong> </strong>registering a<strong> </strong>CAGR of<strong> 10.25% </strong>during the forecast period. The demand for effective treatment, vaccination, and other rare disease therapeutics is anticipated to propel the growth of the global monkeypox therapeutics market during the forecast period.</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Expected Market Value (2023)</th><td>US$ 93.84 million</td></tr><tr><th scope='row'>Anticipated Forecast Value (2033)</th><td>US$ 249 million</td></tr><tr><th scope='row'>Projected Growth Rate (2023 to 2033)</th><td>CAGR 10.25%</td></tr></tbody></table><p>Report Scope</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Market Value in 2023</th><td>US$ 93.84 million</td></tr><tr><th scope='row'>Market Value in 2033</th><td>US$ 249 million</td></tr><tr><th scope='row'>Growth Rate</th><td>CAGR of 10.25% from 2023 to 2033</td></tr><tr><th scope='row'>Base Year for Estimation</th><td>2022</td></tr><tr><th scope='row'>Historical Data</th><td>2018 to 2022</td></tr><tr><th scope='row'>Forecast Period</th><td>2023 to 2033</td></tr><tr><th scope='row'>Quantitative Units</th><td>Revenue in USD million and CAGR from 2023 to 2033</td></tr><tr><th scope='row'>Report Coverage</th><td>Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis</td></tr><tr><th scope='row'>Segments Covered</th><td><ul><li>Treatment Type</li><li>Route of Administration</li><li>Distribution Channel</li><li>Region</li></ul></td></tr><tr><th scope='row'>Regions Covered</th><td><ul><li>North America</li><li>Latin America</li><li>Europe</li><li>Asia Pacific</li><li>Middle East and Africa</li></ul></td></tr><tr><th scope='row'>Key Countries Profiled</th><td><ul><li>United States</li><li>Canada</li><li>Brazil</li><li>Mexico</li><li>Germany</li><li>United Kingdom</li><li>France</li><li>Spain</li><li>Italy</li><li>Indonesia</li><li>China</li><li>Japan</li><li>Malaysia</li><li>Singapore</li><li>Thailand</li><li>South Korea</li><li>Australia</li><li>New Zealand</li><li>GCC Countries</li><li>South Africa</li><li>Israel</li></ul></td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>SIGA Technologies Inc.</li><li>Chimerix, Inc.</li><li>Bavarian Nordic</li><li>Sanofi SA</li><li>Emcure Pharmaceuticals</li><li>Jinan Jinda Pharmaceutical Chemistry Co., Ltd</li><li>Emergent Pharmaceuticals</li><li>Gilead Sciences, Inc.</li><li>Hetero</li><li>Piramal Pharma Solutions</li></ul></td></tr><tr><th scope='row'>Customization</th><td>Available Upon Request</td></tr></tbody></table>

<p>全球猴痘治疗市场预计在2023年将达到约93.84亿美元的估值，并预测到2033年将增长至249亿美元，在预测期间实现10.25%的复合年增长率。对有效治疗、疫苗接种以及其他罕见病治疗的需求预计将推动全球猴痘治疗市场在预测期间的增长。</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>2023年预期市场价值</th><td>93.84亿美元</td></tr><tr><th scope='row'>预测的预测期价值（2033年）</th><td>249亿美元</td></tr><tr><th scope='row'>2023年至2033年预测增长率</th><td>复合年增长率10.25%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>2023年市场价值</th><td>93.84亿美元</td></tr><tr><th scope='row'>2033年市场价值</th><td>249亿美元</td></tr><tr><th scope='row'>增长率</th><td>2023年至2033年复合年增长率10.25%</td></tr><tr><th scope='row'>估算基准年</th><td>2022年</td></tr><tr><th scope='row'>历史数据</th><td>2018年至2022年</td></tr><tr><th scope='row'>预测期</th><td>2023年至2033年</td></tr><tr><th scope='row'>定量单位</th><td>以亿美元计的收入和2023年至2033年的复合年增长率</td></tr><tr><th scope='row'>报告覆盖范围</th><td>收入预测、体积预测、公司排名、竞争格局、增长因素、趋势和定价分析</td></tr><tr><th scope='row'>涵盖的细分市场</th><td><ul><li>治疗类型</li><li>给药途径</li><li>分销渠道</li><li>地区</li></ul></td></tr><tr><th scope='row'>涵盖的地区</th><td><ul><li>北美</li><li>拉丁美洲</li><li>欧洲</li><li>亚太地区</li><li>中东和非洲</li></ul></td></tr><tr><th scope='row'>概述的关键国家</th><td><ul><li>美国</li><li>加拿大</li><li>巴西</li><li>墨西哥</li><li>德国</li><li>英国</li><li>法国</li><li>西班牙</li><li>意大利</li><li>印度尼西亚</li><li>中国</li><li>日本</li><li>马来西亚</li><li>新加坡</li><li>泰国</li><li>韩国</li><li>澳大利亚</li><li>新西兰</li><li>海湾合作委员会国家</li><li>南非</li><li>以色列</li></ul></td></tr><tr><th scope='row'>概述的关键公司</th><td><ul><li>SIGA Technologies Inc.</li><li>Chimerix, Inc.</li><li>Bavarian Nordic</li><li>Sanofi SA</li><li>Emcure Pharmaceuticals</li><li>Jinan Jinda Pharmaceutical Chemistry Co., Ltd</li><li>Emergent Pharmaceuticals</li><li>Gilead Sciences, Inc.</li><li>Hetero</li><li>Piramal Pharma Solutions</li></ul></td></tr><tr><th scope='row'>定制</th><td>根据要求提供</td></tr></tbody></table>